Atlas Trials

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Clinical trial NCT05631938 · COMPLETED

Trial details

NCT number
NCT05631938
Sponsor
Achieve Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2023-01-10
Primary completion
2023-09-04
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.